Neurol. praxi. 2016;17(2):79-86 | DOI: 10.36290/neu.2016.016

Functional movement disorders: a general overview

MUDr. Tereza Serranová, Ph.D.
Neurologická klinika a Centrum klinických neurověd, Univerzita Karlova v Praze, 1. LF a VFN v Praze

Functional (psychogenic) movement disorders are characterized variability and inconsistency of the symptoms, which are incongruent with movement disorders known to be caused by organic neurological disease. The pathophysiology of functional movement disorders is still poorly understood. Previously emphasized causal role of psychological factors was questioned and a neurobiological model of the development of functional symptoms has been proposed. The diagnosis of functional movement disorders should rely on the presence of characteristic clinical features and not on exclusion of organic causis. Early diagnosis and its acceptance by the patient, is essential for the prognosis. Therapeutic strategies consist in multimodal approach with a dominant role of the neurologist, who establishes and communicates the diagnosis and guides the treatment.

Keywords: functional movement disorders, psychogenic movement disorders, inconsistency, inkongruence

Published: February 1, 2016  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Serranová T. Functional movement disorders: a general overview. Neurol. praxi. 2016;17(2):79-86. doi: 10.36290/neu.2016.016.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Akagi H, House A. The epidemiology of hysterical conversion. In: Halligan PW, Bass C, Marshall JC, editors. Contemporary approaches to the study of hysteria: clinical and theoretical perspectives: Oxford: Oxford University Press; 2001: 73-87. Go to original source...
    2. Brown P, Thompson PD. Electrophysiological aids to the diagnosis of psychogenic jerks, spasms, and tremor. Mov Disord. 2001; 16(4): 595-599. Go to original source... Go to PubMed...
    3. Deuschl G, Koster B, Lucking CH, Scheidt C. Diagnostic and pathophysiological aspects of psychogenic tremors. Mov Disord. 1998; 13(2): 294-302. Go to original source... Go to PubMed...
    4. Edwards MJ, Adams RA, Brown H, Parees I, Friston KJ. A Bayesian account of 'hysteria'. Brain. 2012; 135(Pt 11): 3495-3512. Go to original source... Go to PubMed...
    5. Edwards MJ, Bhatia KP. Functional (psychogenic) movement disorders: merging mind and brain. Lancet Neurol. 2012; 11(3): 250-260. Go to original source... Go to PubMed...
    6. Edwards MJ, Stone J, Lang AE. From psychogenic movement disorder to functional movement disorder: It's time to change the name. Mov Disord. 2014 Jul 10. Go to original source... Go to PubMed...
    7. Factor SA, Podskalny GD, Molho ES. Psychogenic movement disorders: frequency, clinical profile, and characteristics. J Neurol Neurosurg Psychiatry. 1995; 59(4): 406-412. Go to original source... Go to PubMed...
    8. Fahn S, Williams DT. Psychogenic dystonia. Adv Neurol. 1988; 50: 431-455.
    9. Fasano A, Valadas A, Bhatia KP, Prashanth LK, Lang AE, Munhoz RP, Morgante F, Tarsy D, Duker AP, Girlanda P, Bentivoglio AR, Espay AJ. Psychogenic facial movement disorders: clinical features and associated conditions. Mov Disord. 2012; 27(12): 1544-1551. Go to original source... Go to PubMed...
    10. Gelauff J, Stone J, Edwards M, Carson A. The prognosis of functional (psychogenic) motor symptoms: a systematic review. J Neurol Neurosurg Psychiatry. 2014; 85(2): 220-226. Go to original source... Go to PubMed...
    11. Gupta A, Lang AE. Psychogenic movement disorders. Curr Opin Neurol. 2009; 22(4): 430-436. Go to original source... Go to PubMed...
    12. Halligan PW, Bass C, Oakley DA. Wilful deception as illness behaviour. In: Halligan PW, Bass C, Oakley DA, editors. Malingering and Illness Deception. Oxford, UK: Oxford University Press; 2003: 3-28. Go to original source...
    13. Jankovic J. Diagnosis and treatment of psychogenic parkinsonism. J Neurol Neurosurg Psychiatry. 2011; 82(12): 1300-1303. Go to original source... Go to PubMed...
    14. Jordbru AA, Smedstad LM, Klungsoyr O, Martinsen EW. Psychogenic gait disorder: A randomized controlled trial of physical rehabilitation with one-year follow-up. J Rehabil Med. 2013 Nov 13. Go to original source... Go to PubMed...
    15. Kompoliti K, Wilson B, Stebbins G, Bernard B, Hinson V. Immediate vs. delayed treatment of psychogenic movement disorders with short term psychodynamic psychotherapy: Randomized clinical trial. Parkinsonism Relat Disord. 2014 Sep 22. Go to original source... Go to PubMed...
    16. Kroenke K. Efficacy of treatment for somatoform disorders: a review of randomized controlled trials. Psychosom Med. 2007; 69(9): 881-888. Go to original source... Go to PubMed...
    17. Lang A. General overview of psychogenic movement disorders: Epidemiology, Diagnosis, and Prognosis: Lippincott Williams & Wilkins; 2006.
    18. Nielsen G, Stone J, Matthews A, Brown M, Sparkes C, Farmer R, Masterton L, Duncan L, Winters A, Daniell L, Lumsden C, Carson A, David AS, Edwards M. Physiotherapy for functional motor disorders: a consensus recommendation. J Neurol Neurosurg Psychiatry. 2015; 86(10): 1113-1119. Go to original source... Go to PubMed...
    19. Parees I, Kojovic M, Pires C, Rubio-Agusti I, Saifee TA, Sadnicka A, Kassavetis P, Macerollo A, Bhatia KP, Carson A, Stone J, Edwards MJ. Physical precipitating factors in functional movement disorders. J Neurol Sci. 2014; 338(1-2): 174-177. Go to original source... Go to PubMed...
    20. Růžička E, Serranová T. Psychogenní poruchy chůze. Neurol. praxi. 2013; 14(4): 182-184.
    21. Serranová T, Růžička E, Roth J. Funkční poruchy hybnosti. Česká a slovenská neurologie a neurochirurgie. 2014; 77(110(3)): 270-286.
    22. Schrag A, Trimble M, Quinn N, Bhatia K. The syndrome of fixed dystonia: an evaluation of 103 patients. Brain. 2004; 127(Pt 10): 2360-2372. Go to original source... Go to PubMed...
    23. Stone J, Carson A, Duncan R, Roberts R, Coleman R, Warlow C, Murray G, Pelosi A, Cavanagh J, Matthews K, Goldbeck R, Sharpe M. Which neurological diseases are most likely to be associated with "symptoms unexplained by organic disease". J Neurol. 2012; 259(1): 33-38. Go to original source... Go to PubMed...
    24. Stone J, Carson A, Sharpe M. Functional symptoms and signs in neurology: assessment and diagnosis. J Neurol Neurosurg Psychiatry. 2005; 76(Suppl 1): i2-12. Go to original source... Go to PubMed...
    25. Stone J, Zeman A, Sharpe M. Functional weakness and sensory disturbance. J Neurol Neurosurg Psychiatry. 2002; 73(3): 241-245. Go to original source... Go to PubMed...
    26. Thompson PD, Colebatch JG, Brown P, Rothwell JC, Day BL, Obeso JA, Marsden CD. Voluntary stimulus-sensitive jerks and jumps mimicking myoclonus or pathological startle syndromes. Mov Disord. 1992; 7(3): 257-262. Go to original source... Go to PubMed...
    27. Voon V, Brezing C, Gallea C, Ameli R, Roelofs K, LaFrance WC, Jr., Hallett M. Emotional stimuli and motor conversion disorder. Brain. 2010; 133(Pt 5): 1526-1536. Go to original source... Go to PubMed...
    28. Wessely S, Nimnuan C, Sharpe M. Functional somatic syndromes: one or many? Lancet. 1999; 354(9182): 936-939. Go to original source... Go to PubMed...

    Return to the content


    Neurology for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.